Cincinnati (Springdale), Ohio

Velocity Clinical Research, Springdale

Velocity's dedicated research site in the Springdale neighborhood of Cincinnati conducts clinical studies on a multitude of medications and devices intended to address health conditions like acne, allergies, chronic diseases, chronic pain, depression, diabetes, hot flashes, hyperlipidemia, hypertension, infectious diseases, migraine headache, smoking cessation, urinary incontinence, vaccines, viral infections, weight loss, and more. Acquired by Velocity in 2022, the Cincinnati location conducted clinical trials for over two decades, first with Sterling Research, then as part of Meridian Clinical Research.

Located just off of I-275, the site is easily accessible to thousands of patients in the tri-state area, including those diverse populations. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Cincinnati team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Velocity Clinical Research, Springdale
375 Glensprings Dr 2nd Floor, Cincinnati, OH 45246

Phone: (513) 671-8080

Email: info@velocityclinical.com

Find a Clinical Trial in Cincinnati (Springdale)
Visit VelocityClinicalTrials.com or follow us on Facebook for study updates and more.

Portrait Of Medical Team Standing Outside Hospital

Our Vision

Improve lives by making clinical research accessible to all.

Our Mission

Improve the clinical research process to accelerate the delivery of new therapies and provide exceptional care to our community.

Our experienced research team in Cincinnati (Springdale)

The Velocity Cincinnati (Springdale) team of physician investigators and clinical research professionals are experienced clinical researchers. All physicians are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Training records and certifications are maintained. Our clinical team is dedicated to conducting quality research in a professional and caring environment and strives on collecting quality data.

  • Matthew Wenkler, MD

    Matthew Wenker, MD

    Principal Investigator, Medical Director
    Matthew Wenker, MD is a board-certified internist with more than a decade of experience in conducting clinical trials. Aside from serving as the Midwest Regional Medical Director and Principal Investigator at Velocity, Dr. Wenker serves as a physician for St. Elizabeth Healthcare, and is a member of the Board of Directors for Caracole, a nonprofit devoted to positively changing lives in the fight against HIV/AIDS in Greater Cincinnati.

  • Douglas K. Logan, MD

    Principal Investigator
    Douglas K. Logan, MD, is a board-certified Internal Medicine physician with over 40 years of medical experience. He earned his medical degree from the University of Cincinnati’s College of Medicine and completed his residency at Christ Hospital in Cincinnati, OH.

    Dr. Logan dedicated 32 years to primary care before transitioning to clinical research, where he spent eight years as a Principal Investigator at a Phase 1 Clinical Pharmacology Unit. His research focused on early drug development for metabolic diseases like dyslipidemia and type 2 diabetes.

    In 2021, Dr. Logan joined Velocity Clinical Research as a Principal Investigator. He also provides medical consultancy for The Affinity Center in Cincinnati, a group specializing in ADHD and related disorders’ evaluation and treatment.

  • Charles Eger, MD

    Principal Investigator
    Charles H. Eger, MD is a board-certified internist who recently retired from practicing medicine for over 35 years to conduct clinical research with Velocity. Joining the team in September 2022, Dr. Eger already has broad expertise in conducting clinical trials, studying vaccines for COVID-19, influenza, RSV, and combinations, as well as novel treatments for Hypertension and other cardiovascular therapeutic areas. Outside of clinical research, Dr. Eger serves on a volunteer board for Christian Villages Communities, a retirement community in Cincinnati.

  • Kelsey Chambers, PA-C

    Sub Investigator
    Kelsey Chambers, PA-C, is a board-certified physician assistant and sub investigator in clinical research at Velocity. She completed her undergraduate studies at Grand Valley State University in Michigan, and then attended Trevecca Nazarene University in Nashville, TN where she completed her Master of Science in Medicine. After obtaining her degree and board certification, Kelsey gained valuable experience working as a physician assistant in family and internal medicine. In September 2021, Kelsey joined Velocity Clinical Research. As a sub investigator, she plays a vital role in conducting clinical research studies, ensuring patient safety, and collecting accurate data.

  • Debra Schroeck, MS, PA-C

    Sub Investigator
    Debra Schroeck, MS, PA-C, has served as a board-certified physician assistant since 2004. She brings a decade of experience in clinical research, with five years focused on psychiatry-specific studies, three years on internal medicine-specific studies, and two years on lipidology studies. Since joining the Springdale, Ohio, team in 2020, she has participated in numerous COVID-19 vaccine research studies, including both mRNA and protein-based vaccine technology platforms that led to Emergency Use Authorizations. Schroeck has also held adjunct faculty positions at National College of Business and Technology and Kettering College and has been a faculty member at the University of Cincinnati. Outside of work, she advocates for twice exceptional children (giftedness plus a diagnosed disability) and actively participates in her local PTO. She also serves as a girls’ Cub Scout den leader. Raised on a farm, Schroeck participated in 4-H from primary school through college. She is bilingual, speaking both English and German.

Cincinnati (Springdale) facility features

The Velocity Clinical Research, Springdale facility is designed for the ease and comfort of study participants and to allow optimal efficiencies in performing clinical trials. Features at this site include:

  • Private examination/consultation rooms
  • Comfortable patient reception areas
  • Facilities for extended-stay pharmacokinetic studies
  • Parking
  • Nursing station
  • Secure monitoring rooms or workstations with phone & high-speed internet access
  • Multiple individual & secure workstations for research staff
  • Regulatory document processing area
  • Electronic data capture (EDC) capabilities
  • Secure record storage
  • CLIA certified research laboratory or clinical laboratory with CLIA waiver
  • Ambient and refrigerated centrifuge
  • Secured & temperature controlled investigational product storage with pharmaceutical refrigerator & freezer
  • Freezers equipped for laboratory specimens at -20 & -70 degrees Celsius
  • Backup generator/power source in the event of site power loss
  • Standard medical equipment, including ECG and Holter machines, digital and analog scales
treatment-3
clinical research site team
Hallandale
Portrait Of Smiling Female Doctor Wearing White Coat With Stethoscope Sitting Behind Desk In Office
treatment

Quality. Continuity. Velocity.